Support of existing NHSBT owned Extracorporial Photopheresis Systems
Estimated value
£5.2m
Awarded value
£8.0m
Suppliers
1
Lots
1
Published
19 Dec 2024
Description
The Therapeutic Apheresis Services (TAS) function operates within the Clinical Services directorate of NHSBT. Multi-disciplinary TAS teams operate from eight regional hub units and three 3 spoke sites that are based within Acute NHS Trusts across England and South Wales. Each unit provides a portfolio of therapeutic treatments to both adult and paediatric patients from across a range of clinical specialities. Included in the TAS portfolio of therapeutic procedures is Extracorporeal Photopheresis (ECP) which is provided from four of the TAS hub units (Bristol, London, Oxford, and Manchester) as well as all three of the spoke sites (the Clatterbridge Cancer Centre, Cardiff and The Vale Health Board and Plymouth University Hospitals Trust). The ECP system's utilised by the TAS teams are able to perform both adult and paediatric procedures and have an integral clinical grade light box. The contract award is for maintenance, training and consumables to support existing Therakos CellEx Extracorporeal Photopheresis machine platforms. This Contract is for a period of 2 years with one 12-month option to extend.
Scope
- Reference
- CF-2762300D0O000000rwimUAA
- Total value
- £5,173,000 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 01 Feb 2025 to 31 Jan 2028
- CPV classifications
- 33140000 50420000
- Particular suitability
- Small and medium-sized enterprises (SME)
Submission & procedure
- Submission deadline
- 19 Dec 2024, 12:00 pm
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£8.0m
Award date
18 Dec 2024
Contract start
01 Feb 2025
Contract end
31 Jan 2028